168 related articles for article (PubMed ID: 16311342)
1. FAT, E-cadherin, beta catenin, HER 2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma.
Settakorn J; Kaewpila N; Burns GF; Leong AS
J Clin Pathol; 2005 Dec; 58(12):1249-54. PubMed ID: 16311342
[TBL] [Abstract][Full Text] [Related]
2. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas.
Li L; Zhang Z; Li B; Gao F; Li L; Jonas JB
Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1867-73. PubMed ID: 21739269
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.
Itatsu K; Zen Y; Ohira S; Ishikawa A; Sato Y; Harada K; Ikeda H; Sasaki M; Nimura Y; Nakanuma Y
Liver Int; 2007 Nov; 27(9):1174-84. PubMed ID: 17919228
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive multiple molecular profile of epithelial mesenchymal transition in intrahepatic cholangiocarcinoma patients.
Huang XY; Zhang C; Cai JB; Shi GM; Ke AW; Dong ZR; Zhang PF; Fan J; Peng BG; Zhou J
PLoS One; 2014; 9(5):e96860. PubMed ID: 24816558
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.
Sugimachi K; Taguchi K; Aishima S; Tanaka S; Shimada M; Kajiyama K; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2001 Sep; 14(9):900-5. PubMed ID: 11557787
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin and β-catenin in two cholangiocarcinoma cell lines (OZ and HuCCT1) with different degree of invasiveness of the primary tumor.
Abuetabh Y; Persad S; Nagamori S; Huggins J; Al-Bahrani R; Sergi C
Ann Clin Lab Sci; 2011; 41(3):217-23. PubMed ID: 22075503
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
[TBL] [Abstract][Full Text] [Related]
10. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver.
Kozyraki R; Scoazec JY; Flejou JF; D'Errico A; Bedossa P; Terris B; Fiorentino M; Bringuier AF; Grigioni WF; Feldmann G
Gastroenterology; 1996 Apr; 110(4):1137-49. PubMed ID: 8613003
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin gene mutations in human intrahepatic cholangiocarcinoma.
Endo K; Ashida K; Miyake N; Terada T
J Pathol; 2001 Mar; 193(3):310-7. PubMed ID: 11241409
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
13. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
Akita M; Sawada R; Komatsu M; Suleman N; Itoh T; Ajiki T; Heaton N; Fukumoto T; Zen Y
Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study.
Ashida K; Terada T; Kitamura Y; Kaibara N
Hepatology; 1998 Apr; 27(4):974-82. PubMed ID: 9537436
[TBL] [Abstract][Full Text] [Related]
15. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
[TBL] [Abstract][Full Text] [Related]
16. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: a guide to adjuvant clinical trials.
Schiffman SC; Nowacki MR; Spencer L; McMasters KM; Scoggins CR; Martin RC
J Surg Oncol; 2014 Feb; 109(2):98-103. PubMed ID: 24122302
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Jun; 14(23):3739-44. PubMed ID: 18595142
[TBL] [Abstract][Full Text] [Related]
18. Correlations of β-catenin, Ki67 and Her-2/neu with gastric cancer.
Wu HW; Qin CY; Huang JL; Kong XY; Wang WJ; Bai WK
Asian Pac J Trop Med; 2014 Apr; 7(4):257-61. PubMed ID: 24507671
[TBL] [Abstract][Full Text] [Related]
19. Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression.
Yu TH; Yuan RH; Chen YL; Yang WC; Hsu HC; Jeng YM
Mod Pathol; 2011 Jun; 24(6):810-9. PubMed ID: 21423153
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of snail expression in hilar cholangiocarcinoma.
Kong D; Liang J; Li R; Liu S; Wang J; Zhang K; Chen D
Braz J Med Biol Res; 2012 Jul; 45(7):617-24. PubMed ID: 22570087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
